Hypera S.A.
HYPE3
株式のランク
#4220
Based in São Paulo, Brazil, Hypera S.A. is a prominent pharmaceutical... Based in São Paulo, Brazil, Hypera S.A. is a prominent pharmaceutical enterprise. The company's comprehensive product line encompasses a wide array of prescription medications, featuring established brands such as Adacne, Celestamine, Cizax, Diprosone, and Emprol XR, among many others. Beyond prescription drugs, Hypera offers specialized dermo-cosmetics through its Mantecorp Skincare brand. Its consumer health division markets popular remedies like Apracur, Benegrip, Engov, and Estomazil. Additionally, Hypera provides nutritional and vitamin supplements, including well-known names such as Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal. The company also maintains a significant presence in the generic and similar medicines market, offering products under the Neo Química brand and common formulations like Ibuprofen, Paracetamol, and Omeprazole. The organization officially became Hypera S.A. in February 2018, having previously operated as Hypermarcas S.A.
株価
$5.32
最終同期: 2026-10-21
時価総額
$3.74B
変化（1日）
2.01%
変化（1年）
24.78%
国
BR
取引 Hypera S.A. (HYPE3)
カテゴリー
Healthcare
Hypera S.A.（HYPE3）の株価履歴
終値の最高値: $5.03 （2026-10-01）
終値の最安値: $4.81 （2008-04-01）
終値の最安値: $4.81 （2008-04-01）
Hypera S.A. の株価履歴（2008 ～ 2026）
年間株価パフォーマンス
| 年 | パフォーマンス |
|---|---|
| 2026 (TTM) | -0.69% |
| 2025 | 45.17% |
| 2024 | -58.10% |
| 2023 | -12.37% |
| 2022 | 62.46% |
| 2021 | -21.43% |
| 2020 | -22.43% |
| 2019 | 1.82% |
| 2018 | -25.66% |
| 2017 | 46.20% |
| 2016 | 28.75% |
| 2015 | -6.93% |
| 2014 | -19.33% |
| 2013 | 0.07% |
| 2012 | 62.59% |
| 2011 | -67.38% |
| 2010 | 28.81% |
| 2009 | 327.96% |
| 2008 | 0.00% |
類似企業または競合の株価
| 企業 | 株価 | 変化率 1年% | 国 |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 20.52% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $212.49 | 24.09% |
CH
|
|
| $19.19 | -0.09% |
IN
|
